<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>HPC药闻药事 | wechat-feeds</title><link>http://MzA3NTQyMTk5Mg.favicon.privacyhide.com/favicon.ico</link><description>传递医药资讯 分享法规知识</description><managingEditor> (hellodword)</managingEditor><pubDate>Tue, 08 Jun 2021 12:05:40 +0800</pubDate><image><url>http://MzA3NTQyMTk5Mg.favicon.privacyhide.com/favicon.ico</url><title>HPC药闻药事 | wechat-feeds</title><link>http://MzA3NTQyMTk5Mg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>关注杜丨创新口服复方药获FDA批准，用于治疗精神分裂症和I型双相情感障碍</title><link>https://mp.weixin.qq.com/s/UflPA9QyiFqc6_fbEU5CYQ</link><description></description><content:encoded><![CDATA[关注杜丨创新口服复方药获FDA批准，用于治疗精神分裂症和I型双相情感障碍]]></content:encoded><pubDate>Tue, 08 Jun 2021 09:03:02 +0800</pubDate></item><item><title>关注杜丨首个治疗妇女阴部念珠菌病的口服药获FDA批准</title><link>https://mp.weixin.qq.com/s/GR750m4bzSphGOIQ4Nh5ow</link><description></description><content:encoded><![CDATA[关注杜丨首个治疗妇女阴部念珠菌病的口服药获FDA批准]]></content:encoded><pubDate>Tue, 08 Jun 2021 09:03:02 +0800</pubDate></item><item><title>​关注杜丨肺癌治疗新突破！全球首款KRAS G12C靶向药物获FDA批准</title><link>https://mp.weixin.qq.com/s/QxEsP7EnEXSJOeFDptYOew</link><description></description><content:encoded><![CDATA[​关注杜丨肺癌治疗新突破！全球首款KRAS G12C靶向药物获FDA批准]]></content:encoded><pubDate>Tue, 01 Jun 2021 10:56:42 +0800</pubDate></item><item><title>关注杜丨FDA批准一款胆管癌治疗新药和首款PSMA-PET前列腺癌显像剂</title><link>https://mp.weixin.qq.com/s/RhD_rO9my03J9pHacqVZIA</link><description></description><content:encoded><![CDATA[关注杜丨FDA批准一款胆管癌治疗新药和首款PSMA-PET前列腺癌显像剂]]></content:encoded><pubDate>Tue, 01 Jun 2021 10:56:42 +0800</pubDate></item><item><title>关注杜丨FDA批准首个肺癌双特异性抗体靶向疗法</title><link>https://mp.weixin.qq.com/s/7kH3-3I9ICbz3dO20-coXw</link><description></description><content:encoded><![CDATA[关注杜丨FDA批准首个肺癌双特异性抗体靶向疗法]]></content:encoded><pubDate>Tue, 25 May 2021 10:57:51 +0800</pubDate></item><item><title>2021首届河套国际医药论坛诚邀您的到来！</title><link>https://mp.weixin.qq.com/s/hTW8IvY5BjZ6LAed0WXAuw</link><description></description><content:encoded><![CDATA[2021首届河套国际医药论坛诚邀您的到来！]]></content:encoded><pubDate>Mon, 10 May 2021 10:04:47 +0800</pubDate></item><item><title>首届深圳福田生物医药创新论坛第二轮通知来啦!5月17号启幕！</title><link>https://mp.weixin.qq.com/s/SQ6P6upNnjHaX69zOKg2nw</link><description></description><content:encoded><![CDATA[首届深圳福田生物医药创新论坛第二轮通知来啦!5月17号启幕！]]></content:encoded><pubDate>Mon, 10 May 2021 10:04:47 +0800</pubDate></item><item><title>【4月28日，线上直播】CAR-T细胞疗法/溶瘤产品的FDA申报策略</title><link>https://mp.weixin.qq.com/s/fkPAKSbnc4dAH2ajBjzSOA</link><description></description><content:encoded><![CDATA[【4月28日，线上直播】CAR-T细胞疗法/溶瘤产品的FDA申报策略]]></content:encoded><pubDate>Sun, 25 Apr 2021 08:46:13 +0800</pubDate></item><item><title>关注杜丨十年来首款，又一多动症治疗新药获FDA批准</title><link>https://mp.weixin.qq.com/s/uiC5Odx8-aIRQHBrAfZrlg</link><description></description><content:encoded><![CDATA[关注杜丨十年来首款，又一多动症治疗新药获FDA批准]]></content:encoded><pubDate>Wed, 07 Apr 2021 10:06:54 +0800</pubDate></item><item><title>关注杜丨又一膀胱功能障碍药物，Myrbetriq获FDA批准</title><link>https://mp.weixin.qq.com/s/CoRcKHYot-FYt2m5AD3UwA</link><description></description><content:encoded><![CDATA[关注杜丨又一膀胱功能障碍药物，Myrbetriq获FDA批准]]></content:encoded><pubDate>Mon, 29 Mar 2021 13:59:59 +0800</pubDate></item><item><title>招聘国际药品注册人员</title><link>https://mp.weixin.qq.com/s/UENV7i46HgZnxl3YNEJiJQ</link><description></description><content:encoded><![CDATA[招聘国际药品注册人员]]></content:encoded><pubDate>Fri, 19 Mar 2021 22:07:49 +0800</pubDate></item><item><title>关注杜丨FDA批准首个抗癌肽偶联药物Pepaxto，治疗多发性骨髓瘤</title><link>https://mp.weixin.qq.com/s/mbl7pveWT9xOnzYA7-7WzQ</link><description></description><content:encoded><![CDATA[关注杜丨FDA批准首个抗癌肽偶联药物Pepaxto，治疗多发性骨髓瘤]]></content:encoded><pubDate>Wed, 03 Mar 2021 09:17:19 +0800</pubDate></item><item><title>关注杜丨FDA批准靶向药物Amondys 45：首个外显子45跳跃型DMD疗法</title><link>https://mp.weixin.qq.com/s/cnY7uvKv2z10lMP6SwtfEQ</link><description></description><content:encoded><![CDATA[关注杜丨FDA批准靶向药物Amondys 45：首个外显子45跳跃型DMD疗法]]></content:encoded><pubDate>Mon, 01 Mar 2021 09:32:41 +0800</pubDate></item></channel></rss>